XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of employee stock options
                               
      Outstanding Options    Vested Options 
 Exercise Price    Number Outstanding at September 30, 2023    Weighted Average Remaining Life    Weighted Average Exercise Price    Number Exercisable at September 30, 2023    Weighted Average Remaining Life    Weighted Average Exercise Price 
$0.80    187,400    6.42   $0.80    187,400    6.42   $0.80 
$4.50    10,000    8.75    4.50    5,000    8.75    4.50 
$4.95    10,000    3.75    4.95    5,000    3.75    4.95 
 Total options    207,400    6.40   $1.18    197,400    6.41   $1.00 
Schedule of stock options outstanding
                 
    Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Intrinsic Value 
 Outstanding at December 31, 2022    207,400   $1.18    7.15 years   $1,091,236 
 Issued    —      —      —      —   
 Exercised    —      —      —      —   
 Outstanding at September 30, 2023    207,400   $1.18    6.40 years   $1,062,200 
 Exercisable at September 30, 2023    197,400   $1.00    6.41 years   $1,046,450 
Schedule of stock warrants
                 
     Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Intrinsic Value 
 Outstanding at December 31, 2022    1,035,000   $7.09    2.6 years   $1,549,400 
 Issued    —      —      —      —   
 Exercised    —      —      —      —   
 Outstanding at September 30, 2023    1,035,000   $7.09    1.83 years   $1,460,500 
 Exercisable at September 30, 2023    1,035,000   $7.09    1.83 years   $1,460,500 
Equity Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of stock options valuation assumptions
        
Assumptions  $4.50 Strike   $4.95 Strike 
(1) dividend yield of   0%   0%
(2) expected volatility of   50%   50%
(3) risk-free interest rate of   3.10%   3.10%
(4) expected life of   10 years    5 years 
(5) estimated fair value  $4.50   $4.50 
Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of stock options valuation assumptions
     
Assumptions  Grant Date 
(1) dividend yield of   0%
(2) expected volatility of   50%
(3) risk-free interest rate of   2.94%
(4) expected life of   5 years 
(5) estimated fair value  $1.17